Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

ACOG Practice Bulletin N. 129. Osteoporosis.

Committee on Practice Bulletins-Gynecology, The American College of Obstetricians and Gynecologists.

Obstet Gynecol. 2012 Sep;120(3):718-34. doi: 10.1097/AOG.0b013e31826dc446. No abstract available.

PMID:
22914492
2.

Postmenopausal osteoporosis: fracture risk and prevention.

Kaunitz AM, McClung MR, Feldman RG, Wysocki S.

J Fam Pract. 2009 Nov;58(11 Suppl Postmenopausal):S1-6.

PMID:
19891943
3.

Screening for osteoporosis.

Croswell J.

Am Fam Physician. 2011 May 15;83(10):1201-2. No abstract available.

4.

Screening for osteoporosis: recommendation statement.

U.S. Preventive Services Task Force.

Am Fam Physician. 2011 May 15;83(10):1197-200. No abstract available.

5.

Postmenopausal osteoporosis: another approach to management.

Cole R.

J Fam Pract. 2010 Jun;59(6):E1-7. No abstract available.

PMID:
20544058
6.

[Pharmacological treatment of post-menopausal osteoporosis].

Gosch M, Kammerlander C, Roth T.

MMW Fortschr Med. 2013 Mar 28;155 Spec No 1(1):42-6; quiz 47-8. Review. German. No abstract available.

PMID:
24260919
7.

Pharmacologic management of osteoporosis.

Fontenot HB, Harris AL.

J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr;43(2):236-45; quiz E20-1. doi: 10.1111/1552-6909.12285. Epub 2014 Feb 6. Review.

PMID:
24502394
8.

Summaries for patients: Osteoporosis treatment based on a woman's probability of fracture.

[No authors listed]

Ann Intern Med. 2010 Nov 2;153(9):I62. doi: 10.7326/0003-4819-153-9-201011020-00003. No abstract available.

PMID:
21041573
9.

Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate.

Kayan K, Johansson H, Oden A, Vasireddy S, Pande K, Orgee J, Kanis JA, McCloskey EV.

Osteoporos Int. 2009 Dec;20(12):2055-61. doi: 10.1007/s00198-009-0942-x. Epub 2009 May 13.

PMID:
19436939
10.

Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures.

Spangler M, Phillips BB, Ross MB, Moores KG.

Am J Health Syst Pharm. 2011 Feb 15;68(4):309-18. doi: 10.2146/ajhp070175. Review.

PMID:
21289325
11.

Real-world challenges of treating osteoporosis.

Owens G.

Am J Manag Care. 2011 May;17 Suppl 6:S177-84. Review.

PMID:
21882487
12.

Factors influencing the treatment of osteoporosis following fragility fracture.

Bessette L, Jean S, Davison KS, Roy S, Ste-Marie LG, Brown JP.

Osteoporos Int. 2009 Nov;20(11):1911-9. doi: 10.1007/s00198-009-0898-x. Epub 2009 Mar 31.

PMID:
19333675
13.

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.

Bruyère O, Collette J, Rizzoli R, Decock C, Ortolani S, Cormier C, Detilleux J, Reginster JY.

Osteoporos Int. 2010 Jun;21(6):1031-6. doi: 10.1007/s00198-009-1078-8. Epub 2009 Oct 8.

PMID:
19813043
14.

Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study.

Sirola J, Salovaara K, Rikkonen T, Kärkkäinen M, Tuppurainen M, Jurvelin JS, Honkanen R, Kröger H.

Osteoporos Int. 2011 Jan;22(1):255-64. doi: 10.1007/s00198-010-1254-x. Epub 2010 Apr 27.

PMID:
20422155
15.

Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk.

Barr RJ, Stewart A, Torgerson DJ, Reid DM.

Osteoporos Int. 2010 Apr;21(4):561-8. doi: 10.1007/s00198-009-1007-x. Epub 2009 Jun 30.

PMID:
19565176
16.

Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.

Øyen J, Gjesdal CG, Brudvik C, Hove LM, Apalset EM, Gulseth HC, Haugeberg G.

Osteoporos Int. 2010 Jul;21(7):1257-67. doi: 10.1007/s00198-009-1068-x. Epub 2009 Oct 8.

PMID:
19813045
17.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group.

Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21.

PMID:
21779819
18.

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures.

Rabenda V, Reginster JY.

Osteoporos Int. 2010 Dec;21(12):1993-2002. doi: 10.1007/s00198-009-1155-z. Epub 2010 Jan 16.

PMID:
20082066
19.

Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.

Ohtori S, Akazawa T, Murata Y, Kinoshita T, Yamashita M, Nakagawa K, Inoue G, Nakamura J, Orita S, Ochiai N, Kishida S, Takaso M, Eguchi Y, Yamauchi K, Suzuki M, Aoki Y, Takahashi K.

J Clin Neurosci. 2010 Feb;17(2):209-13. doi: 10.1016/j.jocn.2009.06.013. Epub 2009 Dec 30.

PMID:
20044258
20.

[Post hip fracture care].

Tandjung R, Rosemann T.

Praxis (Bern 1994). 2011 Jul 27;100(15):917-21. doi: 10.1024/1661-8157/a000614. Review. German.

PMID:
21792807
Items per page

Supplemental Content

Write to the Help Desk